Autologous fat grafting has quietly become one of the most versatile tools in regenerative and aesthetic surgery. Five developments stand out this year.
1. Standardised nanofat protocols. Emulsification and filtration steps are converging toward reproducible, publishable parameters — a prerequisite for real comparative data.
2. SVF characterisation. Better flow-cytometry panels are helping teams understand what is actually being delivered, cell by cell.
3. Volume retention modelling. Imaging follow-up is replacing anecdote when it comes to graft survival.
4. Combination therapy. PRP and microfat used together continue to show promise in wound healing and scar remodelling.
5. Regulatory clarity. Clearer guidance is emerging on what counts as minimal manipulation across jurisdictions.